Eliquis(apixaban)

Stroke risk reduction in AFib; DVT treatment and prevention; pulmonary embolism.

2 DTP programs

From As little as $10/mo

1 platform

FDA-Approved Indications

Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillationTreatment and risk reduction of recurrent DVT and PEDVT prophylaxis following hip or knee replacement surgery

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

Savings card (insured)

via ELIQUIS DTP Program (BMS/Pfizer) · Bristol-Myers Squibb + Pfizer

As little as $10/mo

Co-pay savings card: $10/mo minimum for commercially insured. 30-day free trial also available (first fill $0). Separate from DTP cash program.

Eligibility

Commercially insured patients. Cannot combine with DTP cash program. 30-day free trial available as separate offer.

Visit Program

Last verified: Mar 2026

DTP cash-pay (insurance not accepted)

via ELIQUIS DTP Program (BMS/Pfizer) · Bristol-Myers Squibb + Pfizer

$346/mo

$346 (60 tabs/30-day). Free home delivery all 50 states + PR + USVI. Insurance explicitly NOT accepted. No expiry stated.

Eligibility

Eligible US patients with valid Rx. Cash-pay only — cannot submit to any insurance. Cannot combine with other savings. 340B ineligible.

May purchase at cash price. Cannot seek reimbursement or count toward deductible.

Some benefits may not be available in: MA, CA

Visit Program

Last verified: Mar 2026

Not sure which Eliquis program fits your situation?

Find My Options